These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16004819)

  • 1. [Expressions of CD147 and matrix metalloproteinase-2 in breast cancer and their correlations to prognosis].
    Zhou S; Liu C; Wu SM; Wu RL
    Ai Zheng; 2005 Jul; 24(7):874-9. PubMed ID: 16004819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of CD147, matrix metalloproteinases and transforming growth factor beta1 in breast cancer].
    Xue S; Li SX; Wu ZS; Wang XN; Wu Q; Yang F
    Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):524-8. PubMed ID: 20021962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expressions of CD147, MMP-2 and MMP-9 in laryngeal carcinoma and clinical significance].
    Gou XX; Jin F; Chen HX; Wu WL; Chen L; Zeng Y
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(18):1264-7. PubMed ID: 20646600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and prognostic value of transcriptional factor sp1 in breast cancer].
    Wang XB; Peng WQ; Yi ZJ; Zhu SL; Gan QH
    Ai Zheng; 2007 Sep; 26(9):996-1000. PubMed ID: 17927860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic values of ETS-1, MMP-2 and MMP-9 expression and co-expression in breast cancer patients.
    Puzovic V; Brcic I; Ranogajec I; Jakic-Razumovic J
    Neoplasma; 2014; 61(4):439-46. PubMed ID: 24645837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
    Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
    Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma.
    Ishibashi Y; Matsumoto T; Niwa M; Suzuki Y; Omura N; Hanyu N; Nakada K; Yanaga K; Yamada K; Ohkawa K; Kawakami M; Urashima M
    Cancer; 2004 Nov; 101(9):1994-2000. PubMed ID: 15372476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expressions and significances of CD147, OPN and MMP-2 in oral squamous cell carcinoma].
    Zhang C; Man DP; Ma SM; Cao SW; Li DW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 43(5):683-6. PubMed ID: 23230738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between the expression of matrix metalloproteinase-13 protein and other biomarkers, prognosis in invasive breast cancer].
    Zhang B; Liu YX; Cao WF; Cao XC; Ning LS; Hao XS
    Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):471-6. PubMed ID: 19035119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
    Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
    Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and clinical significance of adhesive molecule CD44v6 in breast invasive ductal carcinoma].
    Lian ZQ; Yang MT; Hou JH; Luo RZ; Wang X; Tang J
    Ai Zheng; 2006 Oct; 25(10):1291-5. PubMed ID: 17059779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor grade and matrix metalloproteinase 2 expression in stromal fibroblasts help to stratify the high-risk group of patients with early breast cancer identified on the basis of st Gallen recommendations.
    Niemiec J; Adamczyk A; Małecki K; Ambicka A; Ryś J
    Clin Breast Cancer; 2013 Apr; 13(2):119-28. PubMed ID: 23375518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-2 (MMP-2) and MMP-9 expression in invasive ductal carcinoma of the breast.
    Sullu Y; Demirag GG; Yildirim A; Karagoz F; Kandemir B
    Pathol Res Pract; 2011 Dec; 207(12):747-53. PubMed ID: 22030137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers of progression and invasion in short term follow up of untreated breast cancer patients.
    Rabi ZA; Todorović-Raković N; Vujasinović T; Milovanović J; Nikolić-Vukosavljević D
    Cancer Biomark; 2015; 15(6):745-54. PubMed ID: 26406416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic evaluation of immunohistochemical CD147 and MMP-2 expression in differentiated thyroid carcinoma.
    Tan H; Ye K; Wang Z; Tang H
    Jpn J Clin Oncol; 2008 Aug; 38(8):528-33. PubMed ID: 18664479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
    Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection.
    Li Y; Xu J; Chen L; Zhong WD; Zhang Z; Mi L; Zhang Y; Liao CG; Bian HJ; Jiang JL; Yang XM; Li XY; Fan CM; Zhu P; Fu L; Chen ZN
    Histopathology; 2009 May; 54(6):677-87. PubMed ID: 19438743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activation and prognostic significance of AKT, NF-kappaB and STAT3 in breast cancer with lymph node metastasis and estrogen receptor expression].
    Liu C; Zhou S; Ke CS; Li NP; Wu RL
    Ai Zheng; 2007 Sep; 26(9):929-36. PubMed ID: 17927847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
    Fan Y; Guan Y; Zhao WH; Li Q; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients.
    Du ZM; Hu CF; Shao Q; Huang MY; Kou CW; Zhu XF; Zeng YX; Shao JY
    Int J Cancer; 2009 Oct; 125(8):1832-41. PubMed ID: 19582878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.